SEC Form 4 · accession 0001123292-26-000994
Tevogen Inc. · TVGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan M Podlogar
Director
Period of report
Jul 10, 2026
Accepted (ET)
Jul 10, 2026 · 5:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001860871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 10, 2026 | A | 40,000 | $0.00 | A | 48,678 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which vests in three equal installments upon the earlier of each of (i) the first anniversary of the grant date and the Issuer having aggregate revenue of $50 million since the grant date, (ii) the second anniversary of the grant date and the Issuer having aggregate revenue of $100 million since the grant date, and (ii) the third anniversary of the grant date and the Issuer having aggregate revenue of $150 million since the grant date, provided that the reporting person remains in service with the Issuer on the applicable vesting date.